The Switzerland market closed on a positive note on Friday after a choppy session, as investors assessed the region's economic data ...

Generic and biosimilar drug producer Sandoz has agreed a $265 million settlement that aims to put allegations of price-fixing brought in a Pennsylvania lawsuit behind it. The agreement – which ...

VAT Group, Swiss Re, Partners Group and ABB gained 0.9 to 1.1%. Sika, Swisscom, Novartis, Lonza Group, Zurich Insurance Group, Roche, Swiss Life Holding and Lindt & Spruengli gained 0.4 to 0.75%.

Novartis' soon-to-be-divested Sandoz unit has positive clinical trial data in hand for a biosimilar of Amgen's blockbuster osteoporosis therapy Prolia (denosumab), clearing the way for regulatory ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

After hours: November 27 at 6:38 PM EST Loading Chart for ICLR ...

Glenmark Pharmaceuticals Inc., USA is pleased to announce the launch of Travoprost Ophthalmic Solution USP, 0.004% (Ionic ...

As of 1:41 p.m. EST. Market Open.